177 related articles for article (PubMed ID: 18827864)
1. The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes.
Spyropoulos AC; Magnuson S; Koh SK
Ther Clin Risk Manag; 2008 Jun; 4(3):653-7. PubMed ID: 18827864
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review.
Poudel DR; Ghimire S; Dhital R; Forman DA; Warkentin TE
Platelets; 2017 Sep; 28(6):614-620. PubMed ID: 28856946
[TBL] [Abstract][Full Text] [Related]
3. Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia.
Sartori M; Cosmi B
TH Open; 2020 Oct; 4(4):e305-e308. PubMed ID: 33103050
[TBL] [Abstract][Full Text] [Related]
4. High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome.
Mohanty E; Nazir S; Sheppard JI; Forman DA; Warkentin TE
J Thromb Haemost; 2019 May; 17(5):841-844. PubMed ID: 30773806
[TBL] [Abstract][Full Text] [Related]
5. Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series.
Warkentin TE; Pai M; Sheppard JI; Schulman S; Spyropoulos AC; Eikelboom JW
J Thromb Haemost; 2011 Dec; 9(12):2389-96. PubMed ID: 21883878
[TBL] [Abstract][Full Text] [Related]
6. Heparin-induced thrombocytopenia: comparison between response to fondaparinux and lepirudin.
Al-Rossaies A; Alkharfy KM; Al-Ayoubi F; Al-Momen A
Int J Clin Pharm; 2011 Dec; 33(6):997-1001. PubMed ID: 22002684
[TBL] [Abstract][Full Text] [Related]
7. Inpatient management strategies in a severe case of heparin-induced thrombocytopenia.
Shmookler AD; Arays R; McCarthy P
Transfus Apher Sci; 2019 Aug; 58(4):525-528. PubMed ID: 31327731
[TBL] [Abstract][Full Text] [Related]
8. [Successful treatment with fondaparinux in heparin-induced thrombocytopenia and thrombosis].
Seculini Patiño CE; Pascualini MF; Tabares AH
Medicina (B Aires); 2015; 75(5):307-10. PubMed ID: 26502466
[TBL] [Abstract][Full Text] [Related]
9. Fondaparinux cross-reactivity in heparin-induced thrombocytopenia successfully treated with high-dose intravenous immunoglobulin and rivaroxaban.
Manji F; Warkentin TE; Sheppard JI; Lee A
Platelets; 2020; 31(1):124-127. PubMed ID: 31397594
[TBL] [Abstract][Full Text] [Related]
10. Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.
Wellborn-Kim JJ; Mitchell GA; Terneus WF; Stowe CL; Malias MA; Sparkman GM; Hanson GW
Am J Health Syst Pharm; 2010 Jul; 67(13):1075-9. PubMed ID: 20554593
[TBL] [Abstract][Full Text] [Related]
11. Successful use of fondaparinux in the setting of heparin-induced thrombocytopenia with thrombosis confirmed by serotonin-release assay and Factor V Leiden.
Fraielli K; Patel D; Wang D; Sargent K; Gore J
J Clin Pharm Ther; 2019 Oct; 44(5):809-812. PubMed ID: 31486123
[TBL] [Abstract][Full Text] [Related]
12. Heparin-Induced Thrombocytopenia at the Emergency Department Due to Intermittent Heparin Flush in a Patient Undergoing Stem Cell Transplant.
Thein KZ; Elsaim SA; Ma MQ; Rojas Hernandez CM; Elsayem A
Cureus; 2022 Nov; 14(11):e31798. PubMed ID: 36569714
[TBL] [Abstract][Full Text] [Related]
13. Fondaparinux as a safe alternative for managing heparin-induced thrombocytopenia in postoperative cardiac surgery patients.
Cegarra-Sanmartín V; González-Rodríguez R; Paniagua-Iglesias P; Santamaría-Ortiz A; Cueva LF; Galán-Serrano J; Moral-García MV
J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):1008-12. PubMed ID: 24439171
[TBL] [Abstract][Full Text] [Related]
14. [Patient who developed heparin-induced thrombocytopenia type II after 24 years on hemodialysis].
Gavranić BB; Basić-Jukić N; Kes P
Acta Med Croatica; 2012 Oct; 66 Suppl 2():68-71. PubMed ID: 23513420
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia.
Warkentin TE; Greinacher A
Thromb Res; 2021 Aug; 204():40-51. PubMed ID: 34144250
[TBL] [Abstract][Full Text] [Related]
16. Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol.
Ghaziri D; Dehaini H; Msheik M; Bahmad M; Zorkot M; Saad GA
BMC Pharmacol Toxicol; 2023 Jan; 24(1):2. PubMed ID: 36639796
[TBL] [Abstract][Full Text] [Related]
17. Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia.
Bream-Rouwenhorst HR; Hobbs RA
Pharmacotherapy; 2008 Nov; 28(11):1401-7. PubMed ID: 18957000
[TBL] [Abstract][Full Text] [Related]
18. Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients.
Junqueira DR; Zorzela LM; Perini E
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007557. PubMed ID: 28431186
[TBL] [Abstract][Full Text] [Related]
19. Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty.
Hwang SR; Wang Y; Weil EL; Padmanabhan A; Warkentin TE; Pruthi RK
Platelets; 2021 Oct; 32(7):936-940. PubMed ID: 33000657
[TBL] [Abstract][Full Text] [Related]
20. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
